@FierceBiotech: Lilly's losses put pressure on key Alzheimer's program. How will Lechleiter's R&D strategy fare? Article | Follow @FierceBiotech
@JohnCFierce: Ketamine ("Special K") for depression? Being studied in IV form, also new pill. Story | Follow @JohnCFierce
@RyanMFierce: Lilly ($LLY) gained an FDA nod for a linagliptin-metformin combo pill for diabetes partnered with Boehringer. News | Follow @RyanMFierce
@MarkHFierce: A 2,200 year old mummy had prostate cancer. Researchers say the finding proves cancer is caused by genetics. More | Follow @MarkHFierce
> Generic drugmaker Watson Pharmaceuticals ($WPI) aims to house its global R&D center in North Brunswick, NJ. Article
> The FDA has stamped an approval on Jentadueto, Eli Lilly's ($LLY) pill that combines two drugs and is partnered with Boehringer Ingelheim. Report
> NPS Pharmaceuticals ($NPSP) said that the FDA has accepted in app for approval of the drug Gattex for treating short bowel syndrome. Release
Pharma News
@FiercePharma: Two chairmen replaced as J&J takes another crack at overhauling McNeil, WSJ reports. Article | Follow @FiercePharma
> Turkish drugmaker wooed by GSK, Pfizer, Bloomberg says. More
> WSJ: Another executive shake-up at J&J's McNeil unit. Article
> Pfizer, Lilly earnings drop on new generic rivals. News
> Depressed study subjects spell relief with Special K. Story
Research News
> New target could be key to beating back methamphetamine addiction. More
> Meet cancer's latest enemy: grape seed extract. Article
> Team finds 2 mutations that cause pediatric brain cancer. More
> Mutated melanoma receptor heightens diabetes risk. Story
> Nearly $11M to fund new Joslin Diabetes Center research facility. Item
Pharma Manufacturing News
> Teva's Cephalon recalls leukemia drug over fragments in vial. News
> Pfizer workers at manufacturing hub sue over whiplashed retirement plans. Article
> Company whistleblower program part of Ranbaxy consent decree. News
> Gutted J&J consumer healthcare plant another year from reopening. Story
> Medicines Company, APP settlement includes manufacturing agreement. Item
And Finally... GlaxoSmithKline CEO Andrew Witty shared his thoughts with the U.K.'s Guardian about the Bill Gates-backed initiative involving 13 pharma groups to combat deadly tropical diseases. Item